126 related articles for article (PubMed ID: 37668307)
1. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array.
Bernstein EF; Basilavecchio LD; Wang J
Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307
[TBL] [Abstract][Full Text] [Related]
2. A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.
Manuskiatti W; Yan C; Tantrapornpong P; Cembrano KAG; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2021 Jan; 53(1):95-103. PubMed ID: 32865858
[TBL] [Abstract][Full Text] [Related]
3. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
[TBL] [Abstract][Full Text] [Related]
4. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
[No Abstract] [Full Text] [Related]
6. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 755-nm picosecond alexandrite laser versus 1064-nm Q-switched Nd:YAG laser for melasma: A randomized, split-face controlled, 2-year follow-up study.
Zhou Y; Li Y; Hamblin MR; Wen X
Lasers Surg Med; 2024 Mar; 56(3):263-269. PubMed ID: 38282099
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis.
Feng J; Shen S; Song X; Xiang W
Lasers Med Sci; 2023 Mar; 38(1):84. PubMed ID: 36897459
[TBL] [Abstract][Full Text] [Related]
9. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma.
Hong JK; Shin SH; Park SJ; Seo SJ; Park KY
J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
Geddes ER; Stout AB; Friedman PM
Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
[TBL] [Abstract][Full Text] [Related]
12. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
13. Low-power fractional CO₂ laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study.
Jalaly NY; Valizadeh N; Barikbin B; Yousefi M
Am J Clin Dermatol; 2014 Aug; 15(4):357-63. PubMed ID: 24858737
[TBL] [Abstract][Full Text] [Related]
14. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
[TBL] [Abstract][Full Text] [Related]
15. The effect of a dual-wavelength 532 nm and 1064 nm picosecond-domain laser with a fractionated holographic optic on photoaging and patient age perception: A pilot study.
Leight-Dunn H; Hadi A; Patel F; Yao CJ; Tu YM; Chapas A
J Cosmet Dermatol; 2022 Jan; 21(1):320-326. PubMed ID: 34908229
[TBL] [Abstract][Full Text] [Related]
16. Pulsed alexandrite laser for treatment of melasma in Asian patients.
Cheng CY; Huang YL; Lee MC; Chang SL; Lin YF; Hu S
J Cosmet Laser Ther; 2017 Aug; 19(4):210-214. PubMed ID: 28151024
[TBL] [Abstract][Full Text] [Related]
17. Objective and Long-Term Evaluation of the Efficacy and Safety of a 1064-nm Picosecond Laser With Fractionated Microlens Array for the Treatment of Atrophic Acne Scar in Asians.
Manuskiatti W; Punyaratabandhu P; Tantrapornpong P; Yan C; Cembrano KAG
Lasers Surg Med; 2021 Sep; 53(7):899-905. PubMed ID: 33326626
[TBL] [Abstract][Full Text] [Related]
18. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
Gokalp H; Akkaya AD; Oram Y
J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
[TBL] [Abstract][Full Text] [Related]
19. The role of 755-nm alexandrite picosecond laser in melasma management.
Pulumati A; Jaalouk D; Algarin YA; Nouri K
Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
[TBL] [Abstract][Full Text] [Related]
20. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
